Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study

被引:0
|
作者
Vallerie V. McLaughlin
Pavel Jansa
Jens E. Nielsen-Kudsk
Michael Halank
Gérald Simonneau
Ekkehard Grünig
Silvia Ulrich
Stephan Rosenkranz
Miguel A. Gómez Sánchez
Tomás Pulido
Joanna Pepke-Zaba
Joan Albert Barberá
Marius M. Hoeper
Jean-Luc Vachiéry
Irene Lang
Francine Carvalho
Christian Meier
Katharina Mueller
Sylvia Nikkho
Andrea M. D’Armini
机构
[1] University of Michigan Health System,Department of Cardiological Medicine
[2] Cardiology and Angiology Department,Thoraxclinic
[3] General University Hospital,Clinic of Pulmonology
[4] Aarhus University,Department III of Internal Medicine
[5] University Hospital Dresden,Unidad de I. Cardiaca e Hipertensión Pulmonar
[6] Hôpital Bicêtre,Department of Pulmonary Medicine, Hospital Clínic
[7] Université Paris-Sud,IDIBAPS
[8] Laboratoire d’Excellence en Recherche sur le Médicament et Innovation Thérapeutique,Département de Cardiologie, Hôpital Erasme
[9] and INSERM Unité 999,Allgemeines Krankenhaus der Stadt Wien
[10] University Hospital Heidelberg,Division of Cardiothoracic Surgery, Foundation “IRCCS Policlinico San Matteo”
[11] University Hospital Zurich,undefined
[12] Cologne University Heart Center,undefined
[13] Hospital Universitario 12 de Octubre,undefined
[14] Instituto Nacional de Cardiología,undefined
[15] National Pulmonary Vascular Diseases Unit,undefined
[16] Papworth Hospital,undefined
[17] University of Barcelona,undefined
[18] and Biomedical Research Networking Center on Respiratory Diseases,undefined
[19] Clinic for Respiratory Medicine,undefined
[20] Hannover Medical School,undefined
[21] Université Libre de Bruxelles,undefined
[22] Medizinische Universität Wien,undefined
[23] Global Development,undefined
[24] Global Medical Affairs,undefined
[25] Bayer AG,undefined
[26] Global Clinical Development,undefined
[27] University of Pavia School of Medicine,undefined
来源
关键词
Riociguat; Chronic thromboembolic pulmonary hypertension; Early access study;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Early Observations on the Use of Riociguat in a Large, Metropolitan Pulmonary Arterial Hypertension/Chronic Thromboembolic Pulmonary Hypertension Treatment Center
    Sulica R.
    Fenton R.
    Cefali F.
    Cardiology and Therapy, 2015, 4 (2) : 209 - 218
  • [42] Relationship between effects of riociguat and levels of methemoglobin in patients with chronic thromboembolic pulmonary hypertension
    Sugimoto, K.
    Nakazato, K.
    Oikawa, M.
    Kobayashi, A.
    Yamaki, T.
    Kunii, H.
    Yoshihisa, A.
    Ishida, T.
    Takeishi, Y.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2295 - 2295
  • [43] Riociguat improves excessive exercise ventilation in patients with inoperable chronic thromboembolic pulmonary hypertension
    Ramos, Roberta Pulcheri
    Figueiredo, Priscila
    Ferreira, Eloara V. M.
    Messina, Carolina
    Oliveira, Rudolf
    Alberto Neder, J.
    Nery, Luiz Eduardo
    Ota Arakaki, Jaquelina Sonoe
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [44] Riociguat For Patients With Chronic Thromboembolic Pulmonary Hypertension: Usefulness Of Transitioning From Phosphodiesterase Type 5 Inhibitor
    Yamamoto, K.
    Tanabe, N.
    Suda, R.
    Sasaki, A.
    Matsumura, A.
    Ema, R.
    Kasai, H.
    Kato, F.
    Sekine, A.
    Nishimura, R.
    Jujo, T.
    Sugiura, T.
    Shigeta, A.
    Sakao, S.
    Tatsumi, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [45] Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry
    Ghofrani, Hossein-Ardeschir
    Gomez Sanchez, Miguel-Angel
    Humbert, Marc
    Pittrow, David
    Simonneau, Gerald
    Gall, Henning
    Gruenig, Ekkehard
    Klose, Hans
    Halank, Michael
    Langleben, David
    Snijder, Repke J.
    Subias, Pilar Escribano
    Mielniczuk, Lisa M.
    Lange, Tobias J.
    Vachiery, Jean-Luc
    Wirtz, Hubert
    Helmersen, Douglas S.
    Tsangaris, Iraklis
    Barbera, Joan A.
    Pepke-Zaba, Joanna
    Boonstra, Anco
    Rosenkranz, Stephan
    Ulrich, Silvia
    Steringer-Mascherbauer, Regina
    Delcroix, Marion
    Jansa, Pavel
    Simkova, Iveta
    Giannakoulas, George
    Klotsche, Jens
    Williams, Evgenia
    Meier, Christian
    Hoeper, Marius M.
    RESPIRATORY MEDICINE, 2021, 178
  • [46] Riociguat for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Update from the EXPERT Registry
    Klose, H.
    Gall, H.
    Ghofrani, H.
    Gruenig, E.
    Humbert, M.
    Simonneau, G.
    Halank, M.
    Langleben, D.
    Snijder, R. J.
    Escribano, P.
    Mielniczuk, L. M.
    Lange, T.
    Vachiery, J.
    Wirtz, H.
    Helmersen, D. S.
    Tsangaris, I.
    Barbera, J. A.
    Pepke-Zaba, J.
    Boonstra, A.
    Rosenkranz, S.
    Ulrich, S.
    Mascherbauer, R.
    Delcroix, M.
    Jansa, P.
    Gomez Sanchez, M. A.
    Klotsche, J.
    Meier, C.
    Pittrow, D.
    Hoeper, M. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [47] Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension
    Kim, Nick H.
    D'Armini, Andrea M.
    Grimminger, Friedrich
    Gruenig, Ekkehard
    Hoeper, Marius M.
    Jansa, Pavel
    Mayer, Eckhard
    Neurohr, Claus
    Simonneau, Gerald
    Torbicki, Adam
    Wang, Chen
    Fritsch, Arno
    Davie, Neil
    Ghofrani, Hossein-Ardeschir
    HEART, 2017, 103 (08) : 599 - 606
  • [48] The impact of riociguat on clinical parameters and quality of life in patients with chronic thromboembolic pulmonary hypertension - results of a retrospective clinical registry
    Jansa, Pavel
    Ambroz, David
    Kuchar, Jan
    Dytrych, Vladimir
    Lindner, Jaroslav
    Linhart, Ales
    BIOMEDICAL PAPERS-OLOMOUC, 2021, 165 (02): : 157 - 161
  • [49] CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH) TREATED WITH RIOCIGUAT: A RETROSPECTIVE, OBSERVATIONAL COHORT STUDY
    Lamia, B.
    Dallongeville, J.
    Bensimon, L.
    Hakme, A.
    Benard, N.
    Levy-Bachelot, L.
    Sitbon, O.
    VALUE IN HEALTH, 2020, 23 : S501 - S501
  • [50] Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
    Alberto M. Marra
    Michael Halank
    Nicola Benjamin
    Eduardo Bossone
    Antonio Cittadini
    Christina A. Eichstaedt
    Benjamin Egenlauf
    Satenik Harutyunova
    Christine Fischer
    Henning Gall
    Hossein Ardeschir Ghofrani
    Marius M. Hoeper
    Tobias J. Lange
    Karen M. Olsson
    Hans Klose
    Ekkehard Grünig
    Respiratory Research, 19